CAS RN: 1042672-97-8

N-[2-Methoxy-4-(4-morpholinyl)phenyl]-2-(3-pyridinyl)-4-thiazolecarboxamide

Product Availability

Choose a grade to view its available package options.

6 package records6 with current stock2 grade groups
Batch No.PackageAvailabilityWarehouseLead TimeInquiry
Batchno.20260510 100mg In stock Inquiry
Batchno.20250503 10mg In stock Inquiry
Batchno.20260117 2mg In stock Inquiry
Batchno.20260513 50mg In stock Inquiry
Batchno.20260623 5mg In stock Inquiry
Batch No.PackageAvailabilityWarehouseLead TimeInquiry
Batchno.20260420 10mg / 25mg / 100mg Confirm by inquiry Shanghai 5-7 business days Inquiry
  • Product code: starshine_CAS1042672-97-8
  • Purity/Analytical Methods: >99.0%
GET A QUOTE

1042672-97-8 / N-(2-methoxy-4-morpholin-4-ylphenyl)-2-pyridin-3-yl-1,3-thiazole-4-carboxamide

IRAK inhibitor 6 | IRAK-IN-6 | N-(2-methoxy-4-morpholinophenyl)-2-(pyridin-3-yl)thiazole-4-carboxamide

Standard CAS: 1042672-97-8 Multi CAS: No

Basic Information

CAS
1042672-97-8
Multi CAS
No
Molecular Formula
C20H20N4O3S
Molecular Weight
396.500000
Exact Mass
396.125612
SMILES
COC1=C(C=CC(=C1)N2CCOCC2)NC(=O)C3=CSC(=N3)C4=CN=CC=C4
InChI
InChI=1S/C20H20N4O3S/c1-26-18-11-15(24-7-9-27-10-8-24)4-5-16(18)22-19(25)17-13-28-20(23-17)14-3-2-6-21-12-14/h2-6,11-13H,7-10H2,1H3,(H,22,25)
InChIKey
JQSRUVXPODZKAF-UHFFFAOYSA-N
Synonyms
IRAK inhibitor 6 IRAK-IN-6 N-(2-methoxy-4-morpholinophenyl)-2-(pyridin-3-yl)thiazole-4-carboxamide N-(2-methoxy-4-morpholin-4-ylphenyl)-2-pyridin-3-yl-1,3-thiazole-4-carboxamide N-[2-METHOXY-4-(4-MORPHOLINYL)PHENYL]-2-(3-PYRIDINYL)-4-THIAZOLECARBOXAMIDE

Computed Properties

Structural Parameters

Heavy atom count
28
Aromatic heavy atom count
17
Fraction Csp3
0.25
Rotatable bonds
5
H-bond acceptors
7
H-bond donors
1
Molar refractivity
109.32
TPSA
76.58

LogP / Solubility

WLOGP
3.3
MLOGP
2.93
XLogP3
2.4
Consensus LogP
2.88
Log S (ESOL)
-4.5
Class (ESOL)
Slightly soluble
Log S (Ali)
-5.2
Class (Ali)
Slightly soluble
Log S (SILICOS-IT)
-5.58
Class (SILICOS-IT)
Slightly soluble

ADME

GI absorption
High
BBB permeant
Yes
P-gp substrate
No
CYP1A2 inhibitor
Yes
CYP2C19 inhibitor
Yes
CYP2C9 inhibitor
Yes
CYP2D6 inhibitor
Yes
CYP3A4 inhibitor
Yes
Log Kp (skin permeation)
-2.79

Drug-likeness / Medicinal Chemistry

Lipinski
Yes
Ghose
Yes
Veber
Yes
Egan
Yes
Muegge
Yes
Bioavailability score
0.55
Leadlikeness
No
Synthetic Accessibility
3

Get In Touch

Contact Us